- Home
- THRD vs NUW Comparison
THRD vs NUW Comparison
Compare THRD & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- NUW
- Stock Information
- Founded
- THRD 2019
- NUW 2008
- Country
- THRD United States
- NUW United States
- Employees
- THRD N/A
- NUW N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- NUW Investment Managers
- Sector
- THRD Health Care
- NUW Finance
- Exchange
- THRD Nasdaq
- NUW Nasdaq
- Market Cap
- THRD 238.7M
- NUW 245.0M
- IPO Year
- THRD 2022
- NUW N/A
- Fundamental
- Price
- THRD $5.42
- NUW $13.61
- Analyst Decision
- THRD Hold
- NUW
- Analyst Count
- THRD 3
- NUW 0
- Target Price
- THRD $5.00
- NUW N/A
- AVG Volume (30 Days)
- THRD 251.2K
- NUW 45.3K
- Earning Date
- THRD 08-07-2025
- NUW 01-01-0001
- Dividend Yield
- THRD N/A
- NUW 3.66%
- EPS Growth
- THRD N/A
- NUW N/A
- EPS
- THRD N/A
- NUW N/A
- Revenue
- THRD N/A
- NUW N/A
- Revenue This Year
- THRD N/A
- NUW N/A
- Revenue Next Year
- THRD N/A
- NUW N/A
- P/E Ratio
- THRD N/A
- NUW N/A
- Revenue Growth
- THRD N/A
- NUW N/A
- 52 Week Low
- THRD $3.18
- NUW $12.45
- 52 Week High
- THRD $16.02
- NUW $14.44
- Technical
- Relative Strength Index (RSI)
- THRD 68.70
- NUW 49.83
- Support Level
- THRD $5.41
- NUW $13.54
- Resistance Level
- THRD $5.52
- NUW $13.76
- Average True Range (ATR)
- THRD 0.05
- NUW 0.08
- MACD
- THRD -0.01
- NUW 0.00
- Stochastic Oscillator
- THRD 64.29
- NUW 31.82
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About NUW Nuveen AMT-Free Municipal Value Fund
Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations. The fund predominantly invests in long-term municipal bonds, corporate bonds, short-term municipal bonds, and other assets.